Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 797,000 | 3,784,000 | 2,595,000 | 1,367,000 | 931,000 |
| Depreciation Amortization | 672,000 | 2,697,000 | 2,018,000 | 1,339,000 | 668,000 |
| Income taxes - deferred | 0 | -226,000 | -78,000 | -92,000 | -18,000 |
| Accounts receivable | 164,000 | -576,000 | -408,000 | -346,000 | 89,000 |
| Other Working Capital | -823,000 | -967,000 | -1,525,000 | -1,050,000 | -749,000 |
| Other Operating Activity | 65,000 | 1,327,000 | 977,000 | 787,000 | 162,000 |
| Operating Cash Flow | $875,000 | $6,039,000 | $3,579,000 | $2,005,000 | $1,083,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -168,000 | -171,000 | -85,000 | -134,000 | 2,000 |
| PPE Investments | -354,000 | -1,459,000 | -1,081,000 | -749,000 | -426,000 |
| Net Acquisitions | N/A | -1,867,000 | -1,867,000 | -1,867,000 | -1,191,000 |
| Other Investing Activity | -17,000 | 4,000 | 15,000 | 19,000 | 30,000 |
| Investing Cash Flow | $-539,000 | $-3,493,000 | $-3,018,000 | $-2,731,000 | $-1,585,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500,000 | 2,284,000 | 2,909,000 | 2,633,000 | 2,284,000 |
| Debt Issued | 0 | 5,409,000 | 3,430,000 | 3,430,000 | N/A |
| Debt Repayment | N/A | -6,012,000 | -3,083,000 | -2,311,000 | -2,311,000 |
| Common Stock Issued | 77,000 | 308,000 | 209,000 | 153,000 | 43,000 |
| Common Stock Repurchased | -152,000 | -645,000 | -548,000 | -477,000 | -336,000 |
| Dividend Paid | -918,000 | -3,616,000 | -2,711,000 | -1,807,000 | -903,000 |
| Other Financing Activity | -8,000 | -2,688,000 | -276,000 | 443,000 | 273,000 |
| Financing Cash Flow | $-501,000 | $-4,960,000 | $-70,000 | $2,064,000 | $-950,000 |
| Exchange Rate Effect | -39,000 | 243,000 | 317,000 | -223,000 | -122,000 |
| Beginning Cash Position | 1,543,000 | 3,714,000 | 3,714,000 | 3,714,000 | 3,714,000 |
| End Cash Position | 1,339,000 | 1,543,000 | 4,521,000 | 4,828,000 | 2,140,000 |
| Net Cash Flow | $-204,000 | $-2,171,000 | $808,000 | $1,114,000 | $-1,574,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 875,000 | 6,039,000 | 3,579,000 | 2,005,000 | 1,083,000 |
| Capital Expenditure | -354,000 | -1,459,000 | -1,081,000 | -749,000 | -426,000 |
| Free Cash Flow | 521,000 | 4,580,000 | 2,498,000 | 1,256,000 | 657,000 |